Cargando...
Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study
PURPOSE: In the past 10 years, the number of available therapeutic options for patients with metastatic colorectal cancer (MCRC) has expanded from fluorouracil (FU) -based therapy to include irinotecan and oxaliplatin. The temporal impact of these advances on the overall survival of a population-bas...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
American Society of Clinical Oncology
2009
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2795424/ https://ncbi.nlm.nih.gov/pubmed/20856627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.0942001 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|